CRISM Therapeutics Corp. is a biotechnology company, which engages in the development of cancer treatment drugs for solid tumors. It offers ChemoSeed product which is a biodegradable drug delivery technology designed for the delivery of chemotherapy directly into cancer tissue. Its services include formulation and consultancy. It operates through the Head Office and Scientific Research segments. The Head Office segment focuses on the administrative in nature and undertaken from the United Kingdom. The Scientific Research segment relates to the work being undertaken on its key research program, ChemoSeed for glioma, and any income associated with it in the form of grants or consultancy. The company was founded in March 2016 and is headquartered in Road Town, British Virgin Islands.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Crism Therapeutics Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Crism Therapeutics Corp market cap is $4.4M.
What is the 52-week high for Crism Therapeutics Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Crism Therapeutics Corp 52 week high is $0.0423 as of October 10, 2025.
What is the 52-week low for Crism Therapeutics Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Crism Therapeutics Corp 52 week low is $0.0423 as of October 10, 2025.
What is Crism Therapeutics Corp stock price today?
Crism Therapeutics Corp stock price today is $6.77.
What was Crism Therapeutics Corp stock price yesterday?
Crism Therapeutics Corp stock price yesterday was $0.1985.
What is the PE ratio of Crism Therapeutics Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Crism Therapeutics Corp’s P/E ratio is -0.70.
What is the Price-to-Book ratio of Crism Therapeutics Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Crism Therapeutics Corp P/B ratio is 0.9270.
What is the 50-day moving average of Crism Therapeutics Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Crism Therapeutics Corp 50-day moving average is $0.0423.